Frontiers
US$ 21.80
soul trial oral semaglutide cardiovascular outcomes 2024 results nejm Reduces CV Events in T2DM β (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine π§ͺ T2DM + ASCVD/CKD π Oral semaglutide 14 mg vs placebo π PDF) Oral Semaglutide and Cardiovascular
Description
Glutamine links obesity to inflammation in human white adipose tissue
Even brief exposure to heatsuch as leaving a pen on a sunny windowsillcan reduce effectiveness without visible changes to the liquid itself
In this study, there was no meaningful difference in the amount of weight lost based on the type of bariatric surgery that had been performed
Thats another reason theyre not going to see the long-term effects. Diede agreed that, at current prices, the economics are difficult to justify purely on cost savings
